
### [NCIT:C7608](http://purl.obolibrary.org/obo/NCIT_C7608)
**Label:** Benign Oral Neoplasm

**Subclasses:** [NCIT:C5910](http://purl.obolibrary.org/obo/NCIT_C5910) (Oral Cavity Lipoma), [NCIT:C7605](http://purl.obolibrary.org/obo/NCIT_C7605) (Oral Cavity Benign Granular Cell Tumor), [NCIT:C6845](http://purl.obolibrary.org/obo/NCIT_C6845) (Oral Cavity Monomorphic Adenoma), [NCIT:C7607](http://purl.obolibrary.org/obo/NCIT_C7607) (Benign Oral Cavity Neoplasm), [NCIT:C27478](http://purl.obolibrary.org/obo/NCIT_C27478) (Gingival Angiofibroma), [NCIT:C5913](http://purl.obolibrary.org/obo/NCIT_C5913) (Oral Cavity Adenoma), [NCIT:C4406](http://purl.obolibrary.org/obo/NCIT_C4406) (Benign Buccal Mucosa Neoplasm), [NCIT:C4598](http://purl.obolibrary.org/obo/NCIT_C4598) (Benign Gingival Neoplasm), [NCIT:C3950](http://purl.obolibrary.org/obo/NCIT_C3950) (Oral Mucosa Lobular Capillary Hemangioma), [NCIT:C4831](http://purl.obolibrary.org/obo/NCIT_C4831) (Gingival Hemangioma), [NCIT:C7734](http://purl.obolibrary.org/obo/NCIT_C7734) (Tongue Lipoma), [NCIT:C3591](http://purl.obolibrary.org/obo/NCIT_C3591) (Benign Lip Neoplasm), [NCIT:C6063](http://purl.obolibrary.org/obo/NCIT_C6063) (Benign Anterior Tongue Neoplasm), [NCIT:C3593](http://purl.obolibrary.org/obo/NCIT_C3593) (Benign Floor of the Mouth Neoplasm), [NCIT:C6242](http://purl.obolibrary.org/obo/NCIT_C6242) (Oral Cavity Pleomorphic Adenoma), [NCIT:C3592](http://purl.obolibrary.org/obo/NCIT_C3592) (Benign Tongue Neoplasm), [NCIT:C5819](http://purl.obolibrary.org/obo/NCIT_C5819) (Buccal Mucosa Papilloma), [NCIT:C5909](http://purl.obolibrary.org/obo/NCIT_C5909) (Oral Cavity Leiomyoma), 

**Class expressions from DL-Learner:**

- Thing 52.26%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) 41.61%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C40388](http://purl.obolibrary.org/obo/NCIT_C40388) (Periductal Breast Myoepitheliosis))) 41.61%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C40384](http://purl.obolibrary.org/obo/NCIT_C40384) (Breast Ductal Adenoma))) 41.61%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C40383](http://purl.obolibrary.org/obo/NCIT_C40383) (Breast Apocrine Adenoma))) 41.61%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C40379](http://purl.obolibrary.org/obo/NCIT_C40379) (Angiosarcoma of the Skin of the Arm after Radical Mastectomy followed by Lymphedema))) 41.61%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C40378](http://purl.obolibrary.org/obo/NCIT_C40378) (Post-Radiotherapy Breast Angiosarcoma))) 41.61%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C40377](http://purl.obolibrary.org/obo/NCIT_C40377) (Breast Follicular Lymphoma))) 41.61%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C40376](http://purl.obolibrary.org/obo/NCIT_C40376) (Breast Burkitt Lymphoma))) 41.61%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C40375](http://purl.obolibrary.org/obo/NCIT_C40375) (Breast Diffuse Large B-Cell Lymphoma))) 41.61%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C4037](http://purl.obolibrary.org/obo/NCIT_C4037) (Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome))) 41.61%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C40369](http://purl.obolibrary.org/obo/NCIT_C40369) (Sebaceous Breast Carcinoma))) 41.61%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C40367](http://purl.obolibrary.org/obo/NCIT_C40367) (Acinic Cell Breast Carcinoma))) 41.61%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C40366](http://purl.obolibrary.org/obo/NCIT_C40366) (Oncocytic Breast Carcinoma))) 41.61%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C40363](http://purl.obolibrary.org/obo/NCIT_C40363) (Nipple Syringomatous Adenoma))) 41.61%


